Infectious Disease Societyof America (IDSA) 47th Annual Meeting Philadelphia, PA October 29

Conference Reports for NATAP


Infectious Disease Societyof America (IDSA) 47th Annual Meeting Philadelphia, PA October 29 - November 1, 2009

	144Week Efficacy & Safety of Raltegravir in TreatmentExperienced Patients, TripleClass Resistant - (11/01/09) (IDSA) TMC278 25mg qd has no effect on corrected QT interval in HIV-negative volunteers - (11/01/09) (IDSA) Predictors of Response in GRACE (Gender, Race And Clinical Experience) - (11/01/09) (IDSA) Darunavir, Ritonavir, and Etravirine Steady-state Pharmacokinetics in the Cervicovaginal Fluid and Blood Plasma of HIV-infected Women Enrolled in the GRACE Study - (11/01/09)